Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

The method effectively induces skin cancer in mice for studying tumor development.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Lower SMAD2/3 activation predicts more severe skin cancer.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

RXRα is crucial for hair growth and skin cell function.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

The HCR gene contributes to psoriasis risk.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

The lump on a woman's scalp was a rare, potentially cancerous tumor from the hair follicle, not a common cyst.